Affymetrix

eBioscience is a prominent provider of reagents essential for immunology and oncology research, specializing in flow cytometry. The company offers a vast array of antibodies, ELISAs, and proteins that support life science research and diagnostics. Recognized as an industry leader, eBioscience is particularly noted for its extensive selection of multicolor flow cytometry reagents, producing over 800 new products annually. Their innovative portfolio encompasses antibodies, fluorochromes, and other reagents tailored for applications in immunology, oncology, cell biology, stem cell biology, and diagnostics. As a privately held entity, eBioscience continues to play a critical role in advancing research capabilities within the pharmaceutical sector.

Panomics, founded in 2000 by Yuling Luo and Jason Li and based in California, specializes in providing a suite of assay products for low to mid-plex genetic, protein, and cellular analysis applications. The company is dedicated to delivering solutions for Parallel Quantitative Biology, which involves a contextual and systems-level measurement of genes, proteins, and their cellular functions. Through its innovative products, Panomics aims to support clients in their research and development efforts across various scientific fields.

Angel Dough Ventures is a startup accelerator that identifies new business ideas as well as develops and launches new products and services into the market. It also reviews customer feedback and analyzes metrics to transform and improve its businesses. Angel Dough Ventures was founded by Andrew Hazen and is headquartered in Hicksville, New York.

Neomorphic, based in Berkeley, California, specializes in computational genomics. It employs proprietary software algorithms and computing infrastructure to analyze, assemble, and annotate genomic and expressed gene sequence data. The company's bioinformatics capabilities have been validated in various scientific projects, including the Drosophila annotation jamboree and the Genome Annotation Assessment Project, demonstrating its superior accuracy in identifying genes and regulatory regions within genomic sequences. Neomorphic's clients comprise prominent pharmaceutical and genomics companies such as Celera Genomics, Millennium Pharmaceuticals, and Monsanto.

Genetic Microsystems is a privately held instrumentation company that specializes in DNA array technology. The company provides advanced genomics research and drug discovery by providing high-performance systems that enable scientists to use micro-array technology in their own labs and in experiments of their own design.